INDP Indaptus Therapeutics Inc

P/E --
Forward P/E --
Price/Sales --
Beta 0.973
Div Yield --
Market Cap --

Company Analysis

Latest News

🟒 Indaptus Therapeutics is trading 5.2% up today as it rebounds from a steep two-day selloff

Indaptus Therapeutics is trading at $1.82 (+5.20%) as the stock stages a volatile rebound following a steep two-day selloff. β€’ The move appears to be a...

INDP Drops 33% From Last Week's Peak β€” Is the Pullback a Reset or a Red Flag for This Micro-Cap Biotech?

INDP Drops 33% From Last Week's Peak β€” Is the Pullback a Reset or a Red Flag for This Micro-Cap Biotech?

Shares of Indaptus Therapeutics tumbled another 14% to $1.75 on Tuesday, extending a punishing slide that has now erased roughly a third of the stock's value...

πŸ”΄ Indaptus Therapeutics is trading 11% down today as profit-taking extends multi-day slide

Indaptus Therapeutics is trading 11% down today at $1.75 as investors continue to lock in profits following a recent sharp rally. β€’ The move extends a period...

πŸ”΄ Indaptus Therapeutics is trading 17.2% down today as Friday's selloff extends amid profit-taking

Indaptus Therapeutics is trading at $2.09 (17.2% down) today as early pre-market strength faded and Friday’s selloff extended into the new week. β€’ The decline...

πŸ”΄ Indaptus Therapeutics is trading 7.3% down today as pre-market gains reverse

Indaptus Therapeutics is trading at $2.42 (-7.28%) as the stock reverses its earlier pre-market rebound. β€’ The decline follows a selloff on Friday, with the...

🟒 Indaptus Therapeutics is trading 10% up today as it rebounds from Friday's pullback

Indaptus Therapeutics is trading at $2.87 (+10%) in pre-market, staging a recovery after shares fell approximately 5–7% during Friday's profit-taking...

πŸ”΄ Indaptus Therapeutics is trading 7.4% down today on profit-taking after recent gains

Indaptus Therapeutics is trading 7.4% down at $2.56 as the stock pulls back following several days of sharp gains earlier this week. β€’ The move comes in the...

πŸ”΄ Indaptus Therapeutics is trading 6.1% down today with no clear catalyst

Indaptus Therapeutics is trading 6.1% down at $2.60 in pre-market sessions after several days of steady gains earlier this week. β€’ There are no fresh...

πŸ”΄ Indaptus Therapeutics is trading 5.1% down today amid broader market weakness

Indaptus Therapeutics is trading 5.1% down at $2.40 today, appearing to track broader market volatility as the Nasdaq Composite declines 1.54%. β€’ The move...

πŸ”΄ Indaptus Therapeutics is trading 10.1% down

Indaptus Therapeutics is trading at $2.54, down 10.1% from a comparison close of $2.82 during regular trading. This is a price-action follow-up, so a separate...

πŸ”΄ Indaptus Therapeutics is trading 6% down today as it consolidates after a recent rally

Indaptus Therapeutics is trading 6% down at $2.65 today, giving back a portion of its recent gains following a sharp move higher on July 15, 2026. * The stock...

🟒 Indaptus Therapeutics is trading 10.5% up

Indaptus Therapeutics is trading at $2.91, up 10.5% from a comparison close of $2.63 during regular trading. This is a price-action follow-up, so a separate...

🟒 Indaptus Therapeutics is trading 6.1% up today on broader risk-on sentiment

Indaptus Therapeutics is trading 6.1% up at $2.79 following several volatile sessions and a recent market rebound. β€’ The move appears driven by broader...

πŸ”΄ Indaptus Therapeutics is trading 6.1% down today as it retreats from a recent rebound

Indaptus Therapeutics is trading at $2.47 (6.1% down), retreating from its recent rebound after experiencing sharp volatility in prior sessions. β€’ There are...

🟒 Indaptus Therapeutics is trading 5.6% up today amid speculative trading

Indaptus Therapeutics is trading 5.6% up today at $2.64 amid speculative trading and market volatility, as no specific company catalysts or regulatory...

πŸ”΄ INDP extends move to 8.4% down

INDP is trading at $2.44, down 8.4% versus the comparison close of $2.67 during regular trading. This is a price-movement alert; no separate company-specific...

Indaptus Therapeutics Is Burning Cash, Selling Shares at a Steep Discount, and Asking Investors to Trust the Plan β€” Should They?

Indaptus Therapeutics Is Burning Cash, Selling Shares at a Steep Discount, and Asking Investors to Trust the Plan β€” Should They?

Shares of Indaptus Therapeutics (INDP) slid 7.9% to $2.46 on July 8, extending a brutal 28% decline from $3.41 on June 26. The selloff reflects a convergence...

πŸ”΄ INDP is trading 7.9% down today on dilution fears and financing uncertainty

INDP is trading 7.9% down today at $2.46 as concerns mount over the company's immediate cash needs and the potential for dilutive financing. β€’ The stock...

πŸ”΄ INDP is trading 6.4% down today, extending a multi-day slide amid financing uncertainty

INDP is trading at $2.50 (6.4% down) in pre-market, extending a multi-day slide from $3.41 on June 26 to $2.67 on July 7. β€’ The stock continues to face heavy...

πŸ”΄ INDP is trading 6% down today amid continued volatility and financing uncertainty

INDP is trading approximately 6% down today at $2.68 following a sharp drop in the previous session and ongoing market uncertainty. β€’ No new company filings,...